We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+1.79%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$586M
AUM Growth
-$19.4M
Cap. Flow
-$11.6M
Cap. Flow %
-1.98%
Top 10 Hldgs %
17.48%
Holding
250
New
15
Increased
23
Reduced
114
Closed
18

Top Buys

Rank Stock Value
1
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$4.5M
2
GAMB
Gambling.com
GAMB
+$4.05M
3
AZN icon
AstraZeneca
AZN
+$3.62M
4
GPN icon
Global Payments
GPN
+$3.4M
5
OWL icon
Blue Owl Capital
OWL
+$2.96M

Top Sells

Rank Stock Value
1
WAB icon
Wabtec
WAB
+$4.27M
2
ABBV icon
AbbVie
ABBV
+$3.73M
3
BX icon
Blackstone
BX
+$3.24M
4
GTLB icon
GitLab
GTLB
+$2.72M
5
MDB icon
MongoDB
MDB
+$2.58M

Sector Composition

Rank Sector Weight
1 Technology 36.08%
2 Industrials 13.65%
3 Energy 8.19%
4 Healthcare 7.99%
5 Consumer Discretionary 6.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRK.A icon
126
Berkshire Hathaway Class A
BRK.A
$1.07T
$531K 0.09%
100
– –
KO icon
127
Coca-Cola
KO
$354B
$519K 0.09%
9,270
+100
+1% +$6K
CVS icon
128
CVS Health
CVS
$137B
$477K 0.08%
6,833
– –
HSY icon
129
Hershey
HSY
$35.4B
$432K 0.07%
2,158
– –
PEP icon
130
PepsiCo
PEP
$186B
$421K 0.07%
2,487
+42
+2% +$7.63K
META icon
131
Meta Platforms (Facebook)
META
$1.51T
$421K 0.07%
1,401
– –
IJH icon
132
iShares Core S&P Mid-Cap ETF
IJH
$123B
$384K 0.07%
7,695
-160
-2% -$8.38K
BAC icon
133
Bank of America
BAC
$435B
$383K 0.07%
14,000
-618
-4% -$18.3K
MCD icon
134
McDonald's
MCD
$188B
$368K 0.06%
1,396
+11
+0.8% +$3.14K
CSCO icon
135
Cisco
CSCO
$450B
$365K 0.06%
6,792
– –
PFE icon
136
Pfizer
PFE
$140B
$361K 0.06%
10,877
– –
MRK icon
137
Merck
MRK
$324B
$356K 0.06%
3,459
+3
+0.1% +$323
BX icon
138
Blackstone
BX
$104B
$347K 0.06%
3,242
-31,104
-91% -$3.24M
MDLZ icon
139
Mondelez International
MDLZ
$77.7B
$342K 0.06%
4,925
– –
XNTK icon
140
State Street SPDR NYSE Technology ETF
XNTK
$2.06B
$341K 0.06%
2,079
+1
+0% +$141
BMY icon
141
Bristol-Myers Squibb
BMY
$127B
$335K 0.06%
5,780
-1,000
-15% -$61.3K
ORCL icon
142
Oracle
ORCL
$331B
$335K 0.06%
3,164
+147
+5% +$17K
TXN icon
143
Texas Instruments
TXN
$255B
$330K 0.06%
2,074
– –
WMT icon
144
Walmart Inc
WMT
$871B
$315K 0.05%
5,907
– –
ACN icon
145
Accenture
ACN
$89.9B
$313K 0.05%
1,019
– –
ABBV icon
146
AbbVie
ABBV
$458B
$309K 0.05%
2,070
-25,379
-92% -$3.73M
EPD icon
147
Enterprise Products Partners
EPD
$83.8B
$307K 0.05%
11,204
– –
VEA icon
148
Vanguard FTSE Developed Markets ETF
VEA
$226B
$299K 0.05%
6,832
-54
-0.8% -$2.47K
JNJ icon
149
Johnson & Johnson
JNJ
$635B
$297K 0.05%
1,906
-4
-0.2% -$660
BIV icon
150
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
$281K 0.05%
3,697
+282
+8% +$20.9K
4 5
6
7 8

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Stanley-Laman Group's Q3 2023 Portfolio in Review

As of Q3 2023, Stanley-Laman Group held 250 positions worth $586M, down 3.2% from $605M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Stanley-Laman Group's Q3 2023 filing shows 15 new, 23 increased, 114 reduced and 18 closed positions. Its largest new stake was AstraZeneca: 26,476 shares worth $3.59M. The largest sale was Wabtec, an estimated $4.27M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Industrials and Energy.

  • Stanley-Laman Group's largest Q3 2023 buy was AstraZeneca: 26,476 shares worth $3.59M.
  • Stanley-Laman Group added most to HashiCorp, Inc. Class A Common Stock in Q3 2023, an estimated $4.5M increase.
  • Stanley-Laman Group's biggest Q3 2023 reduction was AbbVie, cutting an estimated $3.73M.
  • Stanley-Laman Group fully exited Wabtec in Q3 2023, selling an estimated $4.27M.
  • Stanley-Laman Group's ten largest holdings make up 17% of its $586M portfolio in Q3 2023.
  • Stanley-Laman Group opened 15 new positions and closed 18 in Q3 2023.
  • Stanley-Laman Group's portfolio value fell 3.2% quarter-over-quarter to $586M.

Based on Stanley-Laman Group's 13F filing for Q3 2023, filed 16 Oct 2023.